Filariasis and lymphoedema
Open Access
- 7 October 2009
- journal article
- review article
- Published by Wiley in Parasite Immunology
- Vol. 31 (11), 664-672
- https://doi.org/10.1111/j.1365-3024.2009.01133.x
Abstract
Among the causes of lymphoedema (LE), secondary LE due to filariasis is the most prevalent. It affects only a minority of the 120 million people infected with the causative organisms of lymphatic filariasis (LF), Wuchereria bancrofti and Brugia malayi/timori, but is clustered in families, indicating a genetic basis for development of this pathology. The majority of infected individuals develop filarial-specific immunosuppression that starts even before birth in cases where mothers are infected and is characterized by regulatory T-cell responses and high levels of IgG4, thus tolerating high parasite loads and microfilaraemia. In contrast, individuals with this pathology show stronger immune reactions biased towards Th1, Th2 and probably also Th17. Importantly, as for the aberrant lymph vessel development, innate immune responses that are triggered by the filarial antigen ultimately result in the activation of vascular endothelial growth factors (VEGF), thus promoting lymph vessel hyperplasia as a first step to lymphoedema development. Wolbachia endosymbionts are major inducers of these responses in vitro, and their depletion by doxycycline in LF patients reduces plasma VEGF and soluble VEGF-receptor-3 levels to those seen in endemic normals preceding pathology improvement. The search for the immunogenetic basis for LE could lead to the identification of risk factors and thus, to prevention; and has so far led to the identification of single-nucleotide polymorphisms (SNP) with potential functional relevance to VEGF, cytokine and toll-like receptor (TLR) genes. Hydrocele, a pathology with some similarity to LE in which both lymph vessel dilation and lymph extravasation are shared sequelae, has been found to be strongly associated with a VEGF-A SNP known for upregulation of this (lymph-)angiogenesis factor.Keywords
This publication has 79 references indexed in Scilit:
- Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled studyMedical Microbiology and Immunology, 2007
- Neonatal tolerance and patent filarial infectionTrends in Parasitology, 2007
- The Spectrum of Disease in Lymphatic FilariasisCiba Foundation symposium, 2007
- Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic FilariasisPLoS Pathogens, 2006
- Prospects for Elimination of Bancroftian Filariasis by Mass Drug Treatment in Pondicherry, India: A Simulation StudyThe Journal of Infectious Diseases, 2003
- The Role of Endosymbiotic Wolbachia Bacteria in the Pathogenesis of River BlindnessScience, 2002
- Wolbachia Bacteria of Filarial NematodesParasitology Today, 1999
- T-cell activation and the balance of antibody isotypes in human lymphatic filariasisParasitology Today, 1995
- Micro-organisms in filarial larvae (Nematoda)Transactions of the Royal Society of Tropical Medicine and Hygiene, 1975